TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction

Benzinga Logo Benzinga By Prnewswire
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction

LakeShore Biopharma has agreed to a going-private merger with Oceanpine Skyline Inc., where shareholders will receive $0.90 per share, representing a 15.4% premium to the previous closing price.

Insights
LSBCF   neutral

The company is being acquired at a modest premium, indicating a strategic transaction without significant distress or extraordinary value